Relief Therapeutics is trading at 5.00 as of the 18th of December 2024; that is 15.74 percent increase since the beginning of the trading day. The stock's open price was 4.32. Relief Therapeutics has about a 44 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 18th of November 2024 and ending today, the 18th of December 2024. Click here to learn more.
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company was founded in 2013 and is based in Geneva, Switzerland. The company has 21.96 M outstanding shares. More on Relief Therapeutics Holding
Relief Therapeutics Holding [RLFTY] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Small-Cap' category with a current market capitalization of 128.93 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Relief Therapeutics's market, we take the total number of its shares issued and multiply it by Relief Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Relief Therapeutics classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 21.96 M outstanding shares.
Relief Therapeutics Holding has accumulated about 29.87 M in cash with (35.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.07.
Check Relief Therapeutics Probability Of Bankruptcy
Picking the right benchmark for Relief Therapeutics otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Relief Therapeutics otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Relief Therapeutics is critical whether you are bullish or bearish towards Relief Therapeutics Holding at a given time. Please also check how Relief Therapeutics' historical prices are related to one of the top price index indicators.
Our tools can tell you how much better you can do entering a position in Relief Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Piotroski F Score Now
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Elected by the shareholders, the Relief Therapeutics' board of directors comprises two types of representatives: Relief Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Relief. The board's role is to monitor Relief Therapeutics' management team and ensure that shareholders' interests are well served. Relief Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Relief Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.